Kosher certification is an independent international quality standard that is increasingly common in food ingredients and retail. Walk into any supermarket in North America or Europe, and you will see that a large proportion of food and beverages are Kosher-certified. In the pharmaceutical export field, Kosher certification is also increasingly becoming a "golden key" for enterprises to open overseas markets.

Shaoxing Jingxin Pharmaceutical Co., Ltd., as a benchmark enterprise in China's pharmaceutical industry, planned to obtain the globally recognized KLBD Kosher certification to further expand into the high-end European and American markets. As Europe's largest Kosher body, KLBD has operated for more than a century, is respected and accepted by all parties worldwide, and its certification mark is widely recognized by manufacturers and consumers globally.
However, KLBD certification of pharmaceutical products faces multiple challenges: the raw material composition is complex and some excipients may involve non-Kosher ingredients, the production process must strictly avoid cross-contamination, and the certification process has stringent requirements for documentation standardization and process transparency. Shaoxing Jingxin Pharmaceutical urgently needed a professional certification partner to crack the technical difficulties and efficiently advance the certification process. After multi-party investigation, since SINOQUAL obtained the Asia-Pacific general agency office authorization of the KLBD Kosher certification body as early as 2010, it has accumulated rich certification service experience and global resource advantages in the pharmaceutical field over the years, successfully serving pharmaceutical companies such as Sinopharm, North China Pharmaceutical, and Zhejiang NHU, becoming Shaoxing Jingxin Pharmaceutical's preferred partner.
To help Shaoxing Jingxin Pharmaceutical obtain the "pass" to enter the international high-end pharmaceutical market, SINOQUAL formed a dedicated service team, providing Jingxin Pharmaceutical with a full-process customized certification plan, accurately overcoming the key bottlenecks of KLBD certification, working with KLBD experts to check the raw materials of Shaoxing Jingxin Pharmaceutical's declared products one by one to ensure full-chain compliance of raw materials. At the same time, it assisted the enterprise in improving the documentation connecting to Kosher standards, provided standardized guidance on the production process, and ensured that process records are traceable and verifiable.

Through the cooperation of both parties, Shaoxing Jingxin Pharmaceutical successfully won the KLBD Kosher certificate. This certificate not only proves that its products meet Jewish religious requirements, but, with KLBD's global credibility, opens the door to the high-end European and American pharmaceutical markets. At the same time, to calmly cope with Indonesia's mandatory Halal certification policy for pharmaceutical products before October 2026, Shaoxing Jingxin Pharmaceutical, together with SINOQUAL, successfully obtained BPJPH Halal certification. With dual certifications in hand, Shaoxing Jingxin Pharmaceutical's going-global path is further secured!
From raw material review to certificate landing, SINOQUAL, with its service philosophy of being "professional, focused, and dedicated," once again demonstrated its leading advantage in Halal & Kosher certification services in the pharmaceutical field. In the future, SINOQUAL will continue to rely on global certification resources and technical accumulation to help more Chinese pharmaceutical companies break through trade barriers and achieve international brand value upgrades.
FAQ
- Which certifications did Shaoxing Jingxin Pharmaceutical Co., Ltd. obtain through SINOQUAL?
- Shaoxing Jingxin Pharmaceutical Co., Ltd., with SINOQUAL's assistance, successfully won European KLBD Kosher certification and Indonesia's official BPJPH Halal dual certification, opening the door to the global high-end pharmaceutical market. As Europe's largest Kosher body, KLBD has operated for more than a century and its certification mark is widely recognized globally. KLBD certification of pharmaceutical products faces challenges such as complex raw material composition, excipients possibly involving non-Kosher ingredients, and the need to strictly avoid cross-contamination. SINOQUAL obtained the KLBD Asia-Pacific general agency office authorization as early as 2010, having served pharmaceutical companies such as Sinopharm, North China Pharmaceutical, and Zhejiang NHU, and provided Jingxin Pharmaceutical with a full-process customized certification plan. The BPJPH Halal dual certification also helps Jingxin cope with Indonesia's mandatory Halal certification policy for pharmaceutical products before October 2026.
